Enfermedades infecciosas y del sistema inmunitario

Resistencias bacterianas y antimicrobianos

José Miguel Cisneros Herreros
José Miguel Cisneros Herreros
IBiS
Campus Hospital Universitario Virgen del Rocío
Avda. Manuel Siurot, s/n.
41013 · Sevilla
Laboratorio: 218
Manuel Enrique Jiménez Mejías
Manuel Enrique Jiménez Mejías
IBiS
Campus Hospital Universitario Virgen del Rocío
Avda. Manuel Siurot, s/n.
41013 · Sevilla
Laboratorio: 208

José Miguel Cisneros Herreros

Volver al programa
  1. Miembros del grupo
  2. Áreas de trabajo
  3. Publicaciones

Grupo: Resistencias bacterianas y antimicrobianos

Directorio
Miembros del grupo Resistencias bacterianas y antimicrobianos
  • Alarcón González, César Arístides.Doctor en Medicina y Cirugía. FEA (HUVR).
  • Álvarez Marín, Rocío.Dra. en Medicina y Cirugía. Investigadora Juan Rodés. (HUVR).
  • Cebreros Cangueiro, Tania.Lda. en Biología. Predoctoral.
  • Cisneros Herreros, José Miguel.Doctor en Medicina y Cirugía. FEA. (HUVR).
  • Crespo Rivas, Juan Carlos.Doctor en Microbiología
  • García Gutiérrez, Manuel.Doctor en Medicina
  • Guisado Gil, Ana Belén.Investigadora Predoctoral Río Hortega
  • Hermansson, Erik Albin.Ingeniero en Nanobiomedicina
  • Infante Domínguez, Carmen.Doctora en Microbiología. Investigadora.
  • Jiménez Mejías, Manuel Enrique.Doctor en Medicina y Cirugía. FEA (HUVR).
  • Lomas Cabezas, José Manuel.FEA HUVR
  • Luque Márquez, Rafael.Ldo. en Medicina y Cirugía. FEA (HUVR).
  • Molina Gil-Bermejo, José .Ldo. en Medicina y Cirugía. FEA. (HUVR).
  • Navarro Amuedo, M Dolores.Lda. en Medicina. MIR.
  • Pachón Ibáñez, María Eugenia.Doctora en Biología. Investigadora Estabilizada del Programa Nicolás Monardes del Sistema Andaluz de Salud.
  • Peñalva Moreno, Germán.Ldo. Veterinaria. Predoctoral.
  • Praena Segovia, Julia.Lda. en Medicina. FEA.
  • Sánchez González, Silvia.Investigadora en Formación. Lda. en Biología
  • Silva Sánchez, María del Mar.Diplomada en Enfermería

Áreas de trabajo

 Líneas: 

 Infecciones relacionadas con la asistencia sanitaria y optimización del uso de antimicrobianos.

En esta línea se realizan proyectos de formación transversal para mejorar el uso de los antimicrobianos disponibles, mediante nuevas técnicas educativas y la utilización de las nuevas tecnologías de la información, tanto en el marco del hospital como de atención primaria, pues el consumo de antibióticos en ella representa el 90% del total, y para el control de las infecciones relacionadas con la asistencia sanitaria (IRAS).
Al mismo tiempo se realizan ensayos ensayos clínicos para conocer a utilizar mejor los antibióticos disponibles, con el análisis de estudios farmacocinéticos/farmacodinámicos, y de nuevos protocolos para evaluar la duración más adecuada de los tratamientos.
La medición del impacto ecológico de estos estudios se realiza para conseguir pruebas que demuestren el resultado en salud que representa el mejor uso de los antimicrobianos, mediante indicadores clínicos y experimentales.
La evaluación del impacto se realiza determinando la densidad de las infecciones relacionadas con la asistencia sanitaria, particularmente con bacterias multirresistentes, y por Clostridium difficile, y a nivel experimental mediante la determinación de la diversidad de la microbiota en los pacientes.

 

Nuevos tratamientos antimicrobianos en infecciones por bacterias multirresistentes.


A través de esta línea se realizan proyectos de evaluación de nuevos tratamientos antimicrobianos para infecciones por bacterias con diferentes mecanismos de resistencia, tales como Acinetobactar baumannii, Staphylococcus aureus, y enterobacterias productoras de betalactamasas y carbapenemasas (Escherichia coli y Klebsiella pneumoniae).
Igualmente, se desarrollan estudios farmacocinéticos/farmacodinámicos para la evaluación del tratamiento antimicrobiano de infecciones clínicas causadas por bacterias multirresistentes, con el objetivo de optimiar las dosis efectivas en las mismas.
Dentro de esta línea se realizan estudios con antimicrobianos de uso habitual en clínica humana, para evaluar su actividad sobre bacterias con mecanismos de resistencia prevalentes o su uso en nuevas combinaciones, así como también se realizan estudios para la evaluación de nuevos antimicrobianos en fase de desarrollo clínico. Además, se realizan estudios con antimicrobianos, para optimizar su uso y de nuevas moléculas, tanto in vitro como en modelos experimentales de infección.

 

Infecciones endovasculares.


A través de esta línea se realizan proyectos de estudio sobre factores epidemiológicos (endocarditis nosocomial, incidencia en ancianos, evolución a lo largo del tiempo, etc.) en la endocarditis infecciosa, aspectos clínicos relevantes (desarrollo de fracaso ventricular, complicaciones neurológicas, etc.), aspectos microbiológicos (estafilococos, Enterococcus faecalis, Coxiella burnetii) y manejo terapéutico en su vertiente médica y quirúrgica.
También investigamos sobre las infecciones en dispositivos de estimulación eléctrica cardiaca. Diferentes proyectos en esta línea son llevados a cabo como estudios coordinados con otros grupos de investigación españoles, mayormente de la Red Española de Investigación en Patología Infecciosa (Instituto de Salud Carlos III). 

Revistas Internacionales
Mazzotta, S; Cebrero-Cangueiro, T; Frattaruolo, L; Vega-Holm, M; Carretero-Ledesma, M; Sanchez-Cespedes, J; Cappello, AR; Aiello, F; Pachon, J; Vega-Perez, JM; Iglesias-Guerra, F; Pachon-Ibanez, ME
Exploration of piperazine-derived thioureas as antibacterial and anti-inflammatory agents. In vitro evaluation against clinical isolates of colistin-resistant Acinetobacter baumannii
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Rodriguez-Bano, J; Perez-Moreno, MA; Penalva, G; Garnacho-Montero, J; Pinto, C; Salcedo, I; Fernandez-Urrusuno, R; Neth, O; Gil-Navarro, MV; Perez-Milena, A; Sierra, R; Estella, A; Lupion, C; Irastorza, A; Marquez, JL; Pascual, A; Rojo-Martin, MD; Perez-Lozano, MJ; Valencia-Martin, R; Cisneros, JM
Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis
CLINICAL MICROBIOLOGY AND INFECTION
Gomez-Martin, M; Lozano, C; Luque, R; Luque-Romero, L; Rodriguez-Benjumeda, L; Aznar-Martin, J
Red swamp crayfish collecting: a risk activity for leptospirosis
CLINICAL MICROBIOLOGY AND INFECTION
Gerson, S; Lucassen, K; Wille, J; Nodari, CS; Stefanik, D; Nowak, J; Wille, T; Betts, JW; Roca, I; Vila, J; Cisneros, JM; Seifert, H; Higgins, PG
Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Alvarez-Marin, R; Navarro-Amuedo, D; Gasch-Blasi, O; Rodriguez-Martinez, JM; Calvo-Montes, J; Lara-Contreras, R; Lepe-Jimenez, JA; Tubau-Quintano, F; Cano-Garcia, ME; Rodriguez-Lopez, F; Rodriguez-Bano, J; Pujol-Rojo, M; Torre-Cisneros, J; Martinez-Martinez, L; Pascual-Hernandez, A; Jimenez-Mejias, ME; Alvarez-Martinez, R; Calvo, J; de Cueto, M; Cano, ME; de Teran, TD; Dominguez-Herrera, J; Mazarrasa, CF; Gasch, O; Martin-Gandul, C; Diaz, JP; Pujol, M; Puppo, I; Smani, Y; Tubau, F; de la Torre-Cisneros, J
A prospective, multicenter case control study of risk factors for acquisition and mortality in Enterobacter species bacteremia
JOURNAL OF INFECTION
Martin-Gutierrez, G; Penalva, G; de Pipaon, MRP; Aguilar, M; Gil-Navarro, MV; Perez-Blanco, JL; Perez-Moreno, MA; Amaya-Villar, R; Ferraadiz-Millon, C; Gascon, ML; Goycochea-Valdivia, WA; Jimenez-Mejias, ME; Navarro, MD; Lepe, JA; Alvarez-Marin, R; Neth, O; Guisado-Gil, AB; Infante-Dominguez, C; Molina, J; Cisneros, JM
Efficacy and safety of a comprehensive educational antimicrobial stewardship program focused on antifungal use
JOURNAL OF INFECTION
Aguilera, A; Trastoy, R; Rodriguez-Frias, F; Munoz-Bellido, JL; Melon, S; Suarez, A; Orduna, A; Viciana, I; Bernal, S; Garcia-Bujalance, S; Montiel, N; Molina, JM; Basaras, M; Fernandez-Cuenca, F; Garcia-Arata, I; Reina, G; Ocete, MD; Fuentes, A; Navarro-de la Cruz, D; Nieto, L; de Castro, AB; Buti, M; Alvarez, M; Garcia, F
GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000-2016)
JOURNAL OF INFECTION
Macias, M; Fernandez, B; Praena, J
The first neutron time-of-flight line in Spain: Commissioning and new data for the definition of a neutron standard field
RADIATION PHYSICS AND CHEMISTRY
Martinez-Moragon, E; Delgado, J; Mogrovejo, S; Fernandez-Sanchez, T; Lopez, JJ; Orenes, MAM; Montano, PP; Toro, MT; Oliver, BC; Torres, AF; Delgado, PG; Rodriguez, TWJ; Auli, BV; Yebenes, JJZ; Berasategui, MTA; Jimenez, MF; Ruibio, NHD; Azagra, MV; Fernandez, JAA; Sainz, SA; Gonzalez, RMB; Nieves, MEG; Carpio, DA; Selles, NA; Garcia, CB; Lessmann, AC; Carrillo, DD; Pla, JJ; Giraldo, AL; Sanchez, OL; Rivera, CM; Olondris, PM; Gall, XM; Nogues, EP; Coimerma, FP; Carroz, KP; Blanch, AR; Ortun, MLR; Berenguer, DS; Batlles, JS; Mitja, PS; Sagardia, AS; Retes, LS; Combas, JV; Giralte, XV; Zubeldia, IA; Ercoreca, IA; Pena, MH; Pascual, MMI; Michelena, CJ; Castro, AL; Legarreta, AL; Llorente, PL; Prieto, JP; Lorenzo, VZ; Gil, LA; Munoz, JPG; Durantez, MM; Miguel, TP; Ahmida, T; Izquierdo, MIA; Olbah, MA; Munoz, AA; Nunez, IG; Fernandez, DG; Camacho, AL; Pellon, LF; Miguel, EMM; Portal, FO; Raducan, I; Prats, JAR; Segarra, MDS; Soler, FT; Naon, AL; Bonilla, PG; Munoz, FLG; Calderon, PM; Costa, LME; Aparicio, MB; Pazos, JMG; Paz, VG; Barcala, FJG; Sotes, PI; Rodriguez, PJM; Nieto, FM; Orjales, RN; Martin, CS; Antelo, JS; Rodriguez, JT; Espanol, SA; Nieto, CS; Talaverano, GS; Rodriguez, MME; Lopez, JFF; Jimenez, MAL; Vilchez, MJR; Palacin, SC; Quintana, SD; Echeverria, JAN; De La Guardia, EF; Jara, BH; Garcia, VM; Vazquez, LV; De Sus, JC; Villa, JSC; Lopez, JAA; Campillo, EA; Molina, JMC; Venegas, ADS; Martinez, PB; Reinosa, BB; Parra, BF; Garcia, DF; Gutierrez, VS; De Lobera, AVR; Alcon, SL; Gonzalez, FC; Fernandez, TG; Lazaro, JM; Macenlle, NM; Viteri, SA; Amerigo, DA; Bobolea, I; Aguirre, MDC; Contreras, RC; Arias, FC; Alvarez, MC; Martinez, EBD; Campos, RMD; Cano, MDG; Rodriguez, LG; De Tejada, JAGR; Mancebo, EG; Seco, EG; Torralba, FG; Santana, AH; Herrera, PDH; Mosquete, MRH; Rodriguez, PL; Ballesteros, BLM; Vicente, EM; Chacon, BM; Fernandez, AM; Garcia, EM; Castillejo, EO; Serrano, FP; Acevedo, AYP; Rojo, RP; Ruiz-Rico, NQ; Pinedo, AR; Jimenez, BR; Rodriguez, MR; Ingelmo, AR; Pena, AR; Gonzalez, MJS; Trujillo, MJT; Fuertes, LV; Albelda, CV; Meniz, AY; Grovas, RIAP; Ramirez, JARA; Munoz, JMB; Manzanares, MB; Martinez, GD; De Luna, FL; Paez, AM; De Tejada, EOS; Galo, AP; Cornejo, MPE; Esojo, CS; Aleman, AFA; Rumayor, MCA; Espinosa, RA; Mora, RB; Lancharro, FJC; Urra, TG; Martin, SH; Lizaldre, AR; Quintas, RD; Alvarez-Eire, MG; Marquez, HG; Lopez, AG; Bonny, JAC; Villarroel, LJA; Casas, DB; Cid, NB; Paz, AC; Abelaira, MDC; Rio, FI; Sanmartin, AP; Aznar, JMI; Sastre, ML; Hernandez, MCR; Rodriguez, RC; Mendez, AIH; Flores, HKI; Rodriguez, AP; Vazquez, AC; Gallardo, JC; San Juan, JMD; Aguilar, DG; Cardona, AO; Camarero, MO; Bustillo, JP; Feijoo, AV; Tort, NC; Moncin, MD; Garde, MED; De Gregorio, AJM; Gonzalez, AO; Fernandez, IA; Baixauli, EB; Hernandez, NC; Rodriguez, PJC; Damia, AD; Palacios, MAD; Lopez, DEQ; Toledo, RRF; Garcia, DF; Giner, JVG; Lara, SH; Santafe, JJL; Bayo, AL; Calatayud, CM; Seisdedos, LAN; Lopez, FST; Vinuesa, AS; Mengual, EV; Domingo, CAA; Sedano, AC; Abenoza, LA; Barcelona, JA; Sierra, SC; Lazaro, JF; Camo, IJP; Arazuri, NS
Factors that determine the loss of control when reducing therapy by steps in the treatment of moderate-severe asthma in standard clinical practice: A multicentre Spanish study
REVISTA CLINICA ESPANOLA
Guisado-Gil, AB; Mejias-Trueba, M; Alfaro-Lara, ER; Sanchez-Hidalgo, M; Ramirez-Duque, N; Santos-Rubio, MD
Impact of medication reconciliation on health outcomes: An overview of systematic reviews
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY
Penalva, G; Fernandez-Urrusuno, R; Turmo, JM; Hernandez-Soto, R; Pajares, I; Carrion, L; Vazquez-Cruz, I; Botello, B; Garcia-Robredo, B; Camara-Mestres, M; Dominguez-Camacho, JC; Aguilar-Carnerero, MM; Lepe, JA; de Cueto, M; Serrano-Martino, MC; Dominguez-Jimenez, MC; Dominguez-Castano, A; Cisneros, JM; Alcantara, JD; Marin, RA; Vega, AD; de la Cuesta, JD; Fajardo, JM; Moreno, JG; Hevia, E; Irastorza, A; Vazquez, AM; Molina, J; Montero, E; Aguilar, JLP; Remesal, T; Retamar, P; Prieto, ST; Toral, J; Moreno, JT
Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in the community: an interrupted time-series analysis
LANCET INFECTIOUS DISEASES
Kuehl, R; Morata, L; Boeing, C; Subirana, I; Seifert, H; Rieg, S; Kern, WV; Kim, HB; Kim, ES; Liao, CH; Tilley, R; Lopez-Cortes, LE; Llewelyn, MJ; Fowler, VG; Thwaites, G; Cisneros, JM; Scarborough, M; Nsutebu, E; Ferrer, MG; Perez, JL; Barlow, G; Hopkins, S; Ternavasio-de La Vega, HG; Torok, ME; Wilson, P; Kaasch, AJ; Soriano, A
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study
LANCET INFECTIOUS DISEASES
Cullell, N; Carrera, C; Muino, E; Torres-Aguila, NP; Carcel-Marquez, J; Gonzalez-Sanchez, J; Gallego-Fabrega, C; Molina, J; Besora, S; Sotoca, J; Buongiorno, MT; Jimenez-Conde, J; Giralt-Steinhauer, E; de Torres-Chacon, R; Montaner, J; Mancha, F; Cabezas, JA; Marti-Fabregas, J; Prats-Sanchez, L; Camps-Renom, P; Purroy, F; Cambray, S; Freijo, MD; Vives-Bauz, C; Tur, S; Font, MA; Lopez-Cancio, E; Hernandez-Perez, M; Obach, V; Calleja, A; Arenillas, J; Rodriguez-Yanez, M; Castillo, J; Sobrino, T; Fernandez-Cadenas, I; Krupinski, J
Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain
SCIENTIFIC REPORTS
Labrador-Herrera, G; Perez-Pulido, AJ; Alvarez-Marin, R; Casimiro-Soriguer, CS; Cebrero-Cangueiro, T; Moran-Barrio, J; Pachon, J; Viale, AM; Pachon-Ibanez, ME
Virulence role of the outer membrane protein CarO in carbapenem-resistant Acinetobacter baumannii
VIRULENCE
Pintado, V; Pazos, R; Jimenez-Mejias, ME; Rodriguez-Guardado, A; Diaz-Pollan, B; Cabellos, C; Garcia-Lechuz, JM; Lora-Tamayo, J; Domingo, P; Munez, E; Domingo, D; Gonzalez-Romo, F; Lepe-Jimenez, JA; Rodriguez-Lucas, C; Valencia, E; Pelegrin, I; Chaves, F; Pomar, V; Ramos, A; Alarcon, T; Perez-Cecilia, E
Linezolid for therapy ofStaphylococcus aureusmeningitis: a cohort study of 26 patients
INFECTIOUS DISEASES
Gaitan, RM; Boix-Palop, L; Garcia, PM; Mestres, CA; Arriaza, MM; Prieto, AP; Gonzalez, AD; Carretero, EG; Meneses, MH; Sanchez, MAG; Belaustegui, MC; Revuelta, JAO; Arana, JCG; Vazquez, EG; Martinez-Selles, M
Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study
EUROPACE
Gil-Marques, ML; Herrera, GL; Canturri, AM; Pachon, J; Smani, Y; Pachon-Ibanez, ME
Role of PstS in the Pathogenesis of Acinetobacter baumannii Under Microaerobiosis and Normoxia
JOURNAL OF INFECTIOUS DISEASES
Rodriguez-Villodres, N; Gil-Marques, ML; Alvarez-Marin, R; Bonnin, RA; Pachon-Ibanez, ME; Aguilar-Guisado, M; Naas, T; Aznar, J; Pachon, J; Lepe, JA; Smani, Y
Extended-spectrum resistance to beta-lactams/beta-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Cornely, OA; Cisneros, JM; Torre-Cisneros, J; Rodriguez-Hernandez, MJ; Tallon-Aguilar, L; Calbo, E; Horcajada, JP; Queckenberg, C; Zettelmeyer, U; Arenz, D; Rosso-Fernandez, CM; Jimenez-Jorge, S; Turner, G; Raber, S; O'Brien, S; Luckey, A
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Gudiol, C; Arnan, M; Aguilar-Guisado, M; Royo-Cebrecos, C; Sanchez-Ortega, I; Montero, I; Martin-Gandul, C; Laporte-Amargis, J; Albasanz-Puig, A; Nicolae, S; Perayre, M; Berbel, D; Tebe, C; Riera, J; Sureda, A; Cisneros, JM; Carratala, J
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Vazquez-Borrego, MC; Gupta, V; Ibanez-Costa, A; Gahete, MD; Venegas-Moreno, E; Toledano-Delgado, A; Cano, DA; Blanco-Acevedo, C; Ortega-Salas, R; Japon, MA; Barrera-Martin, A; Vasiljevic, A; Hill, J; Zhang, SW; Halem, H; Solivera, J; Raverot, G; Galvez, MA; Soto-Moreno, A; Paez-Pereda, M; Culler, MD; Castano, JP; Luque, RM
A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors
CLINICAL CANCER RESEARCH
Vazquez-Borrego, MC; L-Lopez, F; Galvez-Moreno, MA; Fuentes-Fayos, AC; Venegas-Moreno, E; Herrera-Martinez, AD; Blanco-Acevedo, C; Solivera, J; Landsman, T; Gahete, MD; Soto-Moreno, A; Culler, MD; Castano, JP; Luque, RM
A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells
NEUROENDOCRINOLOGY
Vazquez-Borrego, MC; Fuentes-Fayos, AC; Herrera-Martinez, AD; Venegas-Moreno, E; L-Lopez, F; Fanciulli, A; Moreno-Moreno, P; Alhambra-Exposito, MR; Barrera-Martin, A; Dios, E; Blanco-Acevedo, C; Solivera, J; Granata, R; Kineman, RD; Gahete, MD; Soto-Moreno, A; Galvez-Moreno, MA; Castano, JP; Luque, RM
Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors
NEUROENDOCRINOLOGY
Cosio, BG; Pascual-Guardia, S; Borras-Santos, A; Peces-Barba, G; Santos, S; Vigil, L; Soler-Cataluna, JJ; Martinez-Gonzalez, C; Casanova, C; Marcos, PJ; Alvarez, CJ; Lopez-Campos, JL; Gea, J; Garcia-Aymerich, J; Molina, J; Roman, M; Moises, J; Szabo, V; Reagan, EA; Estepar, RS; Washko, G; Agusti, A; Faner, R
Phenotypic characterisation of early COPD: a prospective case-control study
ERJ OPEN RESEARCH
Hidalgo-Tenorio, C; Galvez, J; Martinez-Marcos, FJ; Plata-Ciezar, A; De La Torre-Lima, J; Lopez-Cortes, LE; Noureddine, M; Reguera, JM; Vinuesa, D; Garcia, MV; Ojeda, G; Luque, R; Lomas, JM; Lepe, JA; de Alarcon, A
Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis
BMC INFECTIOUS DISEASES
Guisado-Gil, AB; Infante-Dominguez, C; Penalva, G; Praena, J; Roca, C; Navarro-Amuedo, MD; Aguilar-Guisado, M; Espinosa-Aguilera, N; Poyato-Borrego, M; Romero-Rodriguez, N; Aldabo, T; Salto-Alejandre, S; de Pipaon, MRP; Lepe, JA; Martin-Gutierrez, G; Gil-Navarro, MV; Molina, J; Pachon, J; Cisneros, JM
Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections
ANTIBIOTICS-BASEL
Herrera-Espejo, S; Cebrero-Cangueiro, T; Labrador-Herrera, G; Pachon, J; Pachon-Ibanez, ME; Alvarez-Marin, R
In Vitro Activity of Pentamidine Alone and in Combination with Antibiotics against Multidrug-Resistant Clinical Pseudomonas aeruginosa Strains
ANTIBIOTICS-BASEL
Flores-Martinez, A; Venegas-Moreno, E; Dios, E; Remon-Ruiz, P; Gros-Herguido, N; Vazquez-Borrego, MC; Madrazo-Atutxa, A; Japon, MA; Kaen, A; Cardenas-Valdepenas, E; Roldan, F; Castano, JP; Luque, RM; Cano, DA; Soto-Moreno, A
Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features
JOURNAL OF CLINICAL MEDICINE
Guisado-Gil, AB; Munoz-Burgos, M; Ortega-Eslava, A; Garcia-Hernandez, FJ; Santos-Ramos, B
Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides
FARMACIA HOSPITALARIA
Gil-Navarro, MV; Luque-Marquez, R; Baez-Gutierrez, N; Alvarez-Marin, R; Navarro-Amuedo, MD; Praena-Segovia, J; Carmona-Caballero, JM; Fraile-Ramos, E; Lopez-Cortes, LE
Antifungal treatment administered in OPAT programs is a safe and effective option in selected patients
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LOPEZ-CORTES LE, LUQUE R, CISNEROS JM, DOMUS OUTPATIENT ANTIMICROBIAL THERAPY GROUP
NEXT STEP, OUTPATIENT ANTIMICROBIAL THERAPY PROGRAMS AS A TOOL OF STEWARDSHIP PROGRAMS.
CLIN INFECT DIS
PALACIOS-BAENA ZR, DELGADO-VALVERDE M, VALIENTE MENDEZ A, ALMIRANTE B, GOMEZ-ZORRILLA S, BORRELL N, CORZO JE, GURGUI M, DE LA CALLE C, GARCIA-ALVAREZ L, RAMOS L, GOZALO M, MOROSINI MI, MOLINA J, CAUSSE M, PASCUAL A, RODRIGUEZ-BAÑO J, REIPI/GEIRAS-SEIMC BACTERAEMIA-MIC GROUP
IMPACT OF DE-ESCALATION ON PROGNOSIS OF PATIENTS WITH BACTEREMIA DUE TO ENTEROBACTERIACEAE: A POST HOC ANALYSIS FROM A MULTICENTER PROSPECTIVE COHORT.
CLIN INFECT DIS.
PERICÀ S JM, LLOPIS J, GONZALEZ-RAMALLO V, GOENAGA MA, MUÑOZ P, GARCIA-LEONI ME, FARIÑAS MC, PAJARON M, AMBROSIONI J, LUQUE R, GOIKOETXEA J, OTEO JA, CARRIZO E, BODRO M, REGUERA-IGLESIAS JM, NAVAS E, HIDALGO-TENORIO C, MIRO JM, SPANISH COLLABORATION ON ENDOCARDITIS-GRUPO DE APOYO AL MANEJO DE LA ENDOCARDITIS INFECCIOSA EN ESPAÑA (GAMES) INVESTIGATORS
OUTPATIENT PARENTERAL ANTIBIOTIC TREATMENT FOR INFECTIVE ENDOCARDITIS: A PROSPECTIVE COHORT STUDY FROM THE GAMES COHORT.
CLIN INFECT DIS.
PEÑALVA G, HÖGBERG LD, WEIST K, VLAHOVIĆ-PALČEVSKI V, HEUER O, MONNET DL, ESAC-NET STUDY GROUP, EARS-NET STUDY GROUP
DECREASING AND STABILISING TRENDS OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE IN ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE IN SEGMENTED REGRESSION ANALYSIS, EUROPEAN UNION/EUROPEAN ECONOMIC AREA, 2001 TO 2018.
EURO SURVEILL.
BENITO N, MUR I, RIBERA A, SORIANO A, RODRIGUEZ-PARDO D, SORLI L, COBO J, FERNANDEZ-SAMPEDRO M, DEL TORO MD, GUIO L, PRAENA J, BAHAMONDE A, RIERA M, ESTEBAN J, BARAIA-ETXABURU JM, MARTINEZ-ALVAREZ J, JOVER-SAENZ A, DUEÑAS C, RAMOS A, SOBRINO B, EUBA G, MORATA L, PIGRAU C, HORCAJADA JP, COLL P, CRUSI X, ARIZA J, REIPI (SPANISH NETWORK FOR RESEARCH IN INFECTIOUS DISEASE) GROUP FOR THE STUDY OF PROSTHETIC JOINT INFECTIONS / GEIO (GROUP FOR THE STUDY OF OSTEOARTICULAR INFECTIONS), SEIMC (SPANISH SOCIETY OF INFECTIOUS DISEASES AND CLINICAL MICROBIOLO
THE DIFFERENT MICROBIAL ETIOLOGY OF PROSTHETIC JOINT INFECTIONS ACCORDING TO ROUTE OF ACQUISITION AND TIME AFTER PROSTHESIS IMPLANTATION, INCLUDING THE ROLE OF MULTIDRUG-RESISTANT ORGANISMS.
J CLIN MED.
GARCIA-ALVAREZ L, SANZ MM, MARIN M, FARIÑAS MC, MONTEJO M, GOIKOETXEA J, RODRIGUEZ GARCIA R, DE ALARCON A, ALMELA M, FERNANDEZ-HIDALGO N, ALONSO SOCAS MM, GOENAGA MA, NAVAS E, VICIOSO L, OTEO JA, SPANISH COLLABORATION ON ENDOCARDITIS-GRUPO DE APOYO AL MANEJO DE LA ENDOCARDITIS INFECCIOSA EN ESPAÑA (GAMES)
ANTIMICROBIAL MANAGEMENT OF TROPHERYMA WHIPPLEI ENDOCARDITIS: THE SPANISH COLLABORATION ON ENDOCARDITIS (GAMES) EXPERIENCE.
J ANTIMICROB CHEMOTHER
PEREZ A, GATO E, PEREZ-LLARENA J, FERNANDEZ-CUENCA F, GUDE MJ, OVIAÑO M, PACHON ME, GARNACHO J, GONZALEZ V, PASCUAL A, CISNEROS JM, BOU G
HIGH INCIDENCE OF MDR AND XDR PSEUDOMONAS AERUGINOSA ISOLATES OBTAINED FROM PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA IN GREECE, ITALY AND SPAIN AS PART OF THE MAGICBULLET CLINICAL TRIAL.
J ANTIMICROB CHEMOTHER.
MOLINA J, NOGUER M, LEPE JA, PEREZ-MORENO MA, AGUILAR-GUISADO M, LASSO DE LA VEGA R, PEÑALVA G, CRESPO-RIVAS JC, GIL-NAVARRO MV, SALVADOR J, CISNEROS JM
CLINICAL IMPACT OF AN EDUCATIONAL ANTIMICROBIAL STEWARDSHIP PROGRAM ASSOCIATED WITH INFECTIOUS DISEASES CONSULTATION TARGETING PATIENTS WITH CANCER: RESULTS OF A 9-YEAR QUASI-EXPERIMENTAL STUDY WITH AN INTERRUPTED TIME-SERIES ANALYSIS.
J INFECT.
MANGAS EL, RUBIO A, ALVAREZ-MARIN R, LABRADOR-HERRERA G, PACHON J, PACHON-IBAÑEZ ME, DIVINA F, PEREZ-PULIDO AJ
PANGENOME OF ACINETOBACTER BAUMANNII UNCOVERS TWO GROUPS OF GENOMES, ONE OF THEM WITH GENES INVOLVED IN CRISPR/CAS DEFENCE SYSTEMS ASSOCIATED WITH THE ABSENCE OF PLASMIDS AND EXCLUSIVE GENES FOR BIOFILM FORMATION.
MICROB GENOM.
GERSON S, BETTS JW, LUCAßEN K, NODARI CS, WILLE J, JOSTEN M, GÖTTIG S, NOWAK J, STEFANIK D, ROCA I, VILA J, CISNEROS JM, LA RAGIONE RM, SEIFERT H, HIGGINS PG
INVESTIGATION OF NOVEL PMRB AND EPTA MUTATIONS IN ISOGENIC ACINETOBACTER BAUMANNII ISOLATES ASSOCIATED WITH COLISTIN RESISTANCE AND INCREASED VIRULENCE IN VIVO.
ANTIMICROB AGENTS CHEMOTHER.
MORATA L, COBO J, FERNANDEZ-SAMPEDRO M, GUISADO VASCO P, RUANO E, LORA-TAMAYO J, SANCHEZ SOMOLINOS M, GONZALEZ RUANO P, RICO NIETO A, ARNAIZ A, ESTEBANEZ MUÑOZ M, JIMENEZ-MEJIAS ME, LOZANO SERRANO AB, MUÑEZ E, RODRIGUEZ-PARDO D, ARGELICH R, ARROYO A, BARBERO JM, CUADRA F, DEL ARCO A, DEL TORO MD, GUIO L, JIMENEZ-BEATTY D, LOIS N, MARTIN O, MARTINEZ ALVAREZ RM, MARTINEZ-MARCOS FJ, PORRAS L, RAMIREZ M, VERGAS GARCIA J, SORIANO A
SAFETY AND EFFICACY OF PROLONGED USE OF DALBAVANCIN IN BONE AND JOINT INFECTIONS.
ANTIMICROB AGENTS CHEMOTHER.
AYERBE-ALGABA R, GIL-MARQUES ML, MIRO-CANTURRI A, PARRA-MILLAN R, PACHON-IBAÑEZ ME, JIMENEZ-MEJIAS ME, PACHON J, SMANI Y
THE ANTHELMINTIC OXYCLOZANIDE RESTORES THE ACTIVITY OF COLISTIN AGAINST COLISTIN-RESISTANT GRAM-NEGATIVE BACILLI.
INT J ANTIMICROB AGENTS
MACHUCA I, GUTIERREZ-GUTIERREZ B, RIVERA-ESPINAR F, CANO A, GRACIA-AHUFINGER I, GUZMAN-PUCHE J, MARFIL-PEREZ E, PEREZ-NADALES E, CASTON JJ, BONOMO RA, CARMELI Y, PATERSON D, PASCUAL A, MARTINEZ-MARTINEZ L, RODRIGUEZ-BAÑO J, TORRE-CISNEROS J, REIPI/ESGBIS/INCREMENT GROUP
EXTERNAL VALIDATION OF THE INCREMENT-CPE MORTALITY SCORE IN A CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE BACTERAEMIA COHORT: THE PROGNOSTIC SIGNIFICANCE OF COLISTIN RESISTANCE.
INT J ANTIMICROB AGENTS.
BLASCO L, AMBROA A, LOPEZ M, FERNANDEZ-GARCIA L, BLERIOT I, TRASTOY R, RAMOS-VIVAS J, COENYE T, FERNANDEZ-CUENCA F, VILA J, MARTINEZ-MARTINEZ L, RODRIGUEZ-BAÑO J, PASCUAL A, CISNEROS JM, PACHON J, BOU G, TOMAS M
COMBINED USE OF THE AB105-2ΦΔCI LYTIC MUTANT PHAGE AND DIFFERENT ANTIBIOTICS IN CLINICAL ISOLATES OF MULTI-RESISTANT ACINETOBACTER BAUMANNII.
MICROORGANISMS.
PINTADO V, PAZOS R, JIMENEZ-MEJIAS ME, RODRIGUEZ-GUARDADO A, DIAZ-POLLAN B, CABELLOS C, GARCIA-LECHUZ JM, LORA-TAMAYO J, DOMINGO P, MUÑEZ E, DOMINGO D, GONZALEZ-ROMO F, LEPE-JIMENEZ JA, RODRIGUEZ-LUCAS C, GIL A, PELEGRIN I, CHAVES F, POMAR V, RAMOS A, ALARCON T, PEREZ-CECILIA E
STAPHYLOCOCCUS AUREUS MENINGITIS IN ADULTS: A COMPARATIVE COHORT STUDY OF INFECTIONS CAUSED BY METICILLIN-RESISTANT AND METICILLIN-SUSCEPTIBLE STRAINS.
J HOSP INFECT.
ARMIÑANZAS C, FARIÑAS-ALVAREZ C, ZARAUZA J, MUÑOZ P, GONZALEZ RAMALLO V, MARTINEZ SELLES M, MIRO MEDA JM, PERICAS JM, GOENAGA MA, OJEDA BURGOS G, RODRIGUEZ ALVAREZ R, CASTELO CORRAL L, GALVEZ-ACEBAL J, MARTINEZ MARCOS FJ, FARIÑAS MC, SPANISH COLLABORATION ON ENDOCARDITIS — GRUPO DE APOYO AL MANEJO DE LA ENDOCARDITIS INFECCIOSA EN ESPANA STUDY GROUP
ROLE OF AGE AND COMORBIDITIES IN MORTALITY OF PATIENTS WITH INFECTIVE ENDOCARDITIS.
EUR J INTERN MED.
RAMOS-MARTINEZ A, CALDERON-PARRA J, MIRO JM, MUÑOZ P, RODRIGUEZ-ABELLA H, VALERIO M, DE ALARCON A, LUQUE R, AMBROSIONI J, FARIÑAS MC, GOENAGA MA, OTEO JA, MARTINEZ MARCOS FJ, VINUESA D, DOMINGUEZ F, SPANISH COLLABORATION ON ENDOCARDITIS — GRUPO DE APOYO AL MANEJO DE LA ENDOCARDITIS INFECCIOSA EN ESPAÑA (GAMES) (SEE APPENDIX)
EFFECT OF THE TYPE OF SURGICAL INDICATION ON MORTALITY IN PATIENTS WITH INFECTIVE ENDOCARDITIS WHO ARE REJECTED FOR SURGICAL INTERVENTION.
INT J CARDIOL.
VALENCIA-MARTIN R, GONZALEZ-GALAN V, ALVAREZ-MARIN R, CAZALLA-FONCUEVA AM, ALDABO T, GIL-NAVARRO MV, ALONSO-ARAUJO I, MARTIN C, GORDON R, GARCIA-NUÑEZ EJ, PEREZ R, PEÑALVA G, AZNAR J, CONDE M, CISNEROS JM, IN REPRESENTATION OF A. BAUMANNII ERADICATION PROGRAM
A MULTIMODAL INTERVENTION PROGRAM TO CONTROL A LONG-TERM ACINETOBACTER BAUMANNII ENDEMIC IN A TERTIARY CARE HOSPITAL.
ANTIMICROB RESIST INFECT CONTROL
LOPEZ-CORTES LE, AYERBE-GARCIA R, CARRASCO-HERNANDEZ L, FRAILE-RAMOS E, CARMONA-CABALLERO JM, QUINTANA-GALLEGO E, VALIDO-MORALES A, PRAENA J, PACHON-DIAZ J, DOMUS OPAT GROUP
OUTPATIENT PARENTERAL ANTIMICROBIAL TREATMENT FOR NON-CYSTIC FIBROSIS BRONCHIECTASIS EXACERBATIONS: A PROSPECTIVE MULTICENTRE OBSERVATIONAL COHORT STUDY.
RESPIRATION
CUERVO G, GARCIA-VIDAL C, PUIG-ASENSIO M, MERINO P, VENA A, MARTIN-PEÑA A, MONTEJO JM, RUIZ A, LAZARO-PERONA F, FORTUN J, FERNANDEZ-RUIZ M, SUAREZ AI, CASTRO C, CARDOZO C, GUDIOL C, AGUADO JM, PAÑO JR, PEMAN J, SALAVERT M, GARNACHO-MONTERO J, CISNEROS JM, SORIANO A, MUÑOZ P, ALMIRANTE B, CARRATALÀ J, REIPI, THE GEMICOMED (SEIMC) AND THE SPANISH CANDI-BUNDLE GROUP
USEFULNESS OF GUIDELINE RECOMMENDATIONS FOR PROGNOSIS IN PATIENTS WITH CANDIDEMIA.
MED MYCOL
IVANOVA-GEORGIEVA R, RUIZ-MORALES J, GARCIA-CABRERA E, GARCIA-LOPEZ MV, GALVEZ-ACEBAL J, PLATA-CIEZAR A, DE LA TORRE LIMA J, HIDALGO-TENORIO C, MARTINEZ-MARCOS FJ, GARCIA DV, LUQUE R, DE ALARCON GONZALEZ A
LEFT-SIDED INFECTIVE ENDOCARDITIS CAUSED BY STREPTOCOCCUS AGALACTIAE: RARE AND SERIOUS.
EUR J CLIN MICROBIOL INFECT DIS
MITSUWAN W, JIMENEZ-MUNGUIA I, VISUTTHI M, SIANGLUM W, REIPI/GEIH STUDY GROUP, RODRIGUEZ-ORTEGA MJ, VORAVUTHIKUNCHAI SP
RHODOMYRTONE DECREASES STAPHYLOCOCCUS AUREUS SIGB ACTIVITY DURING EXPONENTIALLY GROWING PHASE AND INHIBITS HAEMOLYTIC ACTIVITY WITHIN MEMBRANE VESICLES.
MICROB PATHOG
ERCIBENGOA M, GOENAGA MA, ARDANUY C, GRAU I, GARCIA-DE-LA-MARIA C, ALMELA M, MIRO JM, NAVAS E, FARIÑAS MC, DE ALEGRIA CR, DE LA TORRE J, FERNANDEZ F, MARIN M, MUÑOZ P, ORDEN B, OTEO JA, GARCIA-ALVAREZ L, DE ALARCON A, JIMENEZ JAL, MARIMON JM
EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF STREPTOCOCCUS TIGURINUS ENDOCARDITIS.
BMC INFECT DIS
ROCA-OPORTO C, CEBRERO-CANGUEIRO T, GIL-MARQUES ML, LABRADOR-HERRERA G, SMANI Y, GONZALEZ-RONCERO FM, MARIN LM, PACHON J, PACHON-IBAÑEZ ME, CORDERO E
PREVALENCE AND CLINICAL IMPACT OF STREPTOCOCCUS PNEUMONIAE NASOPHARYNGEAL CARRIAGE IN SOLID ORGAN TRANSPLANT RECIPIENTS.
BMC INFECT DIS
XU J, PACHON-IBAÑEZ ME, CEBRERO-CANGUEIRO T, CHEN H, SANCHEZ-CESPEDES J, ZHOU J
DISCOVERY OF NICLOSAMIDE AND ITS O-ALKYLAMINO-TETHERED DERIVATIVES AS POTENT ANTIBACTERIAL AGENTS AGAINST CARBAPENEMASE-PRODUCING AND/OR COLISTIN RESISTANT ENTEROBACTERIACEAE ISOLATES.
BIOORG MED CHEM LETT
AYERBE ALGABA R, ALVAREZ-MARIN R, PRAENA J, SMANI Y
ESCHERICHIA COLI CAUSING MENINGITIS IN AN ADULT: A CASE REPORT AND EXPERIMENTAL CHARACTERIZATION OF ITS VIRULENCE.
ENFERM INFECC MICROBIOL CLIN
MONTECATINE-ALONSO E, GIL-NAVARRO MV, FERNANDEZ-LLAMAZARES CM, FERNANDEZ-POLO A, SOLER-PALACIN P, LLORENTE-GUTIERREZ J, GOMEZ-TRAVECEDO CALVO MT, ESQUIVEL-MORA MD, PEREZ-RODRIGO I, CISNEROS JM, GOYCOCHEA-VALDIVIA WA, NETH O, PAEDIATRIC ANTIMICROBIAL DEFINED DAILY DOSE STUDY GROUP (KIDDDS)
ANTIMICROBIAL DEFINED DAILY DOSE ADJUSTED BY WEIGHT: A PROPOSAL FOR ANTIBIOTIC CONSUMPTION MEASUREMENT IN CHILDREN.
ENFERM INFECC MICROBIOL CLIN
SANCHEZ-FABRA D, DYAR OJ, DEL POZO JL, AMIGUET JA, COLMENERO JD, FARIÑAS MDC, LOPEZ-MEDRANO F, PORTILLA J, PRAENA J, TORRE-CISNEROS J, RODRIGUEZ-BAÑO J, PULCINI C, PAÑO-PARDO JR, EN REPRESENTACION DE ESGAP (ESCMID STUDY GROUP FOR ANTIMICROBIAL STEWARDSHIP)
PERSPECTIVE OF SPANISH MEDICAL STUDENTS REGARDING UNDERGRADUATE EDUCATION IN INFECTIOUS DISEASES, BACTERIAL RESISTANCE AND ANTIBIOTIC USE.
ENFERM INFECC MICROBIOL CLIN
NOUREDDINE-LOPEZ M, DE LA TORRE-LIMA J, RUIZ-MORALES J, GALVEZ-ACEBAL J, HIDALGO-TENORIO C, DE ALARCON GONZALEZ CA, POR EL GRUPO PARA EL ESTUDIO DE LAS INFECCIONES CARDIOVASCULARES DE LA SOCIEDAD ANDALUZA DE ENFERMEDADES INFECCIOSAS (SAEI)
LEFT ENDOCARDITIS, CHANGES IN THE NEW MILLENNIUM.
MED CLIN (BARC)
GUISADO-GIL AB, HERRERA-HIDALGO L, SANTOS-RUBIO MD, GIL-SACALUGA L, MOLINA J, LEPE-JIMENEZ JA, CAMACHO-MARTINEZ P, GIL-NAVARRO MV
GENTAMICIN AS EMPIRICAL TREATMENT IN HEMODIALYSIS PATIENTS: SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS.
THER APHER DIAL
LEPE JA, RODRIGUEZ-VILLODRES A, MARTIN-GUTIERREZ G, LUQUE R, AZNAR J
IN VITRO STUDY OF SYNERGY OF AMPICILLIN WITH CEFTRIAXONE AGAINST LISTERIA MONOCYTOGENES.
REV ESP QUIMIOTER
MUÑOZ M, CRESPO JC, CRESPO JP, COVEÑAS R
NEUROKININ-1 RECEPTOR ANTAGONIST APREPITANT AND RADIOTHERAPY, A SUCCESSFUL COMBINATION THERAPY IN A PATIENT WITH LUNG CANCER: A CASE REPORT.
MOL CLIN ONCOL.
CISNEROS JM, ROSSO-FERNANDEZ CM, ROCA-OPORTO C, DE PASCALE G, JIMENEZ-JORGE S, FERNANDEZ-HINOJOSA E, MATTHAIOU DK, RAMIREZ P, DIAZ-MIGUEL RO, ESTELLA A, ANTONELLI M, DIMOPOULOS G, GARNACHO-MONTERO J, MAGIC BULLET WORKING GROUP WP1
COLISTIN VERSUS MEROPENEM IN THE EMPIRICAL TREATMENT OF VENTILATOR-ASSOCIATED PNEUMONIA (MAGIC BULLET STUDY): AN INVESTIGATOR-DRIVEN, OPEN-LABEL, RANDOMIZED, NONINFERIORITY CONTROLLED TRIAL.
CRIT CARE.
RODRIGUEZ-VILLODRES A, BONNIN RA, ORTIZ DE LA ROSA JM, ALVAREZ-MARIN R, NAAS T, AZNAR J, PACHON J, LEPE JA, SMANI Y
PHYLOGENY, RESISTOME, AND VIRULOME OF ESCHERICHIA COLI CAUSING BILIARY TRACT INFECTIONS.
J CLIN MED
Russo A, Falcone M, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Cisneros JM, Hernández-Torres A, Farcomeni A, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Rodriguez-Gomez J, Souli M, Bonomo RA, Paterson DL, Carmeli Y, Pascual A, Rodríguez-Baño J, Venditti M; REIPI/ESGBIS/INCREMENT investigators.
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
Int J Antimicrob Agents.
Pulido MR, Moreno-Martínez P, González-Galán V, Fernández Cuenca F, Pascual Á, Garnacho-Montero J, Antonelli M, Dimopoulos G, Lepe JA, McConnell MJ, Cisneros JM; MagicBullet Working Group.
Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia.
Clin Microbiol Infect.
Pérez-Moreno MA, Peñalva-Moreno G, Praena J, González-González A, Martínez-Cañavate MT, Rodríguez-Baño J, Cisneros JM.
Evaluation of the impact of a nationwide massive online open course on the appropriate use of antimicrobials.
J Antimicrob Chemother
Molina J, Peñalva G, Lepe JA, Valencia R, Gil-Navarro MV, Cisneros JM.
Novel Indicators for Enhancing the Clinical Outcome Metrics of Antimicrobial Stewardship Programs.
Infect Control Hosp Epidemiol.
Amat T, Gutiérrez-Pizarraya A, Machuca I, Gracia-Ahufinger I, Pérez-Nadales E, Torre-Giménez Á, Garnacho-Montero J, Cisneros JM, Torre-Cisneros J.
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
Clin Microbiol Infect.
Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Castón JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andújar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual Á, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J, Spanish Society of Transplantation (SET), Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC), Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016).
Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
Transplant Rev (Orlando)
Amat T, Gutiérrez-Pizarraya A, Machuca I, Gracia-Ahufinger I, Pérez-Nadales E, Torre-Giménez Á, Garnacho-Montero J, Cisneros JM, Torre-Cisneros J.
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
Clin Microbiol Infect
Ayerbe Algaba R, Álvarez-Marín R, Praena J, Smani Y.
Escherichia coli causing meningitis in an adult: A case report and experimental characterization of its virulence
Enferm Infecc Microbiol Clin
Ayerbe-Algaba R, Gil-Marqués ML, Jiménez-Mejías ME, Sánchez-Encinales V, Parra-Millán R, Pachón-Ibáñez ME, Pachón J, Smani Y.
Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
Front Cell Infect Microbiol.
Carretero-Ledesma M, García-Quintanilla M, Martín-Peña R, Pulido MR, Pachón J, McConnell MJ.
Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii
Virulence.
Cebrero-Cangueiro T, Álvarez-Marín R, Labrador-Herrera G, Smani Y, Cordero-Matía E, Pachón J, Pachón-Ibáñez ME.
In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae.
Front Cell Infect Microbiol
Cisneros Herreros JM, Peñalva Moreno G.
Crisis of antibiotics: Health professionals, citizens and politicians, we are all responsible.
Enferm Infecc Microbiol Clin
Cuervo G, García-Vidal C, Puig-Asensio M, Merino P, Vena A, Martín-Peña A, Montejo JM, Ruiz A, Lázaro-Perona F, Fortún J, Fernández-Ruiz M, Suárez AI, Castro C, Cardozo C, Gudiol C, Aguado JM, Paño JR, Pemán J, Salavert M, Garnacho-Montero J, Cisneros JM, Soriano A, Muñoz P, Almirante B, Carratalà J, REIPI, the GEMICOMED (SEIMC) and the Spanish CANDI-Bundle Group.
Usefulness of guideline recommendations for prognosis in patients with candidemia.
Med Mycol.
Escolà-Vergé L, Rodríguez-Pardo D, Lora-Tamayo J, Morata L, Murillo O, Vilchez H, Sorli L, Carrión LG, Barbero JM, Palomino-Nicás J, Bahamonde A, Jover-Sáenz A, Benito N, Escudero R, Sampedro MF, Vidal RP, Gómez L, Corona PS, Almirante B, Ariza J, Pigrau C, Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), and the Spanish Network for Research in Infectious Pathology (REIPI).
Candida periprosthetic joint infection: A rare and difficult-to-treat infection.
J Infect.
Fernández-García L, Ambroa A, Blasco L, Bleriot I, López M, Álvarez-Marín R, Fernández-Cuenca F, Martínez-Martínez L, Vila J, Rodríguez-Baño J, Garnacho-Montero J, Cisneros JM, Pascual A, Pachón J, Bou G, Smani Y, Tomás M.
Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii.
Front Microbiol.
Fernández-Hidalgo N, Ferrería-González I, Marsal JR, Ribera A, Aznar ML, de Alarcón A, García-Cabrera E, Gálvez-Acebal J, Sánchez-Espín G, Reguera-Iglesias JM, De La Torre-Lima J, Lomas JM, Hidalgo-Tenorio C, Vallejo N, Miranda B, Santos-Ortega A, Castro MA, Tornos P, García-Dorado D, Almirante B.
A pragmatic approach for mortality prediction after surgery in infective endocarditis: optimizing and refining EuroSCORE.
Clin Microbiol Infect.
Fernández-Hidalgo N, Ribera A, Larrosa MN, Viedma E, Origüen J, de Alarcón A, Fariñas MC, Sáez C, Peña C, Múñez E, García López MV, Gavaldà J, Pérez-Montarelo D, Chaves F, Almirante B.
Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study
Clin Microbiol Infect.
Gil-Marqués ML, Pachón-Ibáñez ME, Pachón J, Smani Y.
Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection
Infect Immun.
Gil-Navarro MV, López-Cortés LE, Luque-Márquez R, Gálvez-Acebal J, de Alarcón-González A.
Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
J Clin Pharm Ther
Gudiol C, Nicolae S, Royo-Cebrecos C, Aguilar-Guisado M, Montero I, Martín-Gandul C, Perayre M, Berbel D, Encuentra M, Arnan M, Cisneros-Herreros JM, Carratalà J.
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Trials
Horcajada JP, Grau S, Paño-Pardo JR, López A, Oliver A, Cisneros JM, Rodríguez-Baño J.
Antimicrobial stewardship in Spain: Programs for Optimizing the use of Antibiotics (PROA) in Spanish hospitals.
Germs.
Kieffer N, Ahmed MO, Elramalli AK, Daw MA, Poirel L, Álvarez R, Nordmann P.
Colistin-resistant carbapenemase-producing isolates among Klebsiella spp. and Acinetobacter baumannii in Tripoli, Libya.
J Glob Antimicrob Resist.
López-Cortés LE, Luque R, Cisneros JM, DOMUS OPAT Group.
Next step, OPAT programs as a tool of stewardship programs.
Clin Infect Dis.
. Mejías-Trueba M, Pérez-Moreno MA, Fernández-Arche MÁ.
Systematic review of the efficacy of statins for the treatment of Alzheimer's disease.
Clin Med (Lond).
Molina J, Peñalva G, Lepe JA, Valencia R, Gil-Navarro MV, Cisneros JM.
Novel Indicators for Enhancing the Clinical Outcome Metrics of Antimicrobial Stewardship Programs.
Infect Control Hosp Epidemiol.
Morales Barroso I, López-Cerero L, Navarro MD, Gutiérrez-Gutiérrez B, Pascual A, Rodríguez-Baño J.
Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence.
Antimicrob Resist Infect Control.
Muñoz L, Santin M, Alcaide F, Ruíz-Serrano MJ, Gijón P, Bermúdez E, Domínguez-Castellano A, Navarro MD, Ramírez E, Pérez-Escolano E, López-Prieto MD, Gutiérrez-Rodríguez J, Anibarro L, Calviño L, Trigo M, Cifuentes C, García-Gasalla M, Payeras A, Gasch O, Espasa M, Agüero R, Ferrer D, Casas X, González-Cuevas A, García-Zamalloa A, Bikuña E, Lecuona M, Galindo R, Ramírez-Lapausa M, Carrillo R, OPTIMIST Study Team .
QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial
Clin Infect Dis.
Noureddine-López M, de la Torre-Lima J, Ruiz-Morales J, Gálvez-Acebal J, Hidalgo-Tenorio C, de Alarcón González CA, por el Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).
Left endocarditis, changes in the new millennium.
Med Clin (Barc)
Núñez-Núñez M, Navarro MD, Palomo V, Rajendran NB, Del Toro MD, Voss A, Sharland M, Sifakis F, Tacconelli E, Rodríguez-Baño J, EPI-Net, Combacte-Magnet and EUCIC Group for SUSPIRE.
The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information.
Clin Microbiol Infect.
Pachón-Ibáñez ME, Labrador-Herrera G, Cebrero-Cangueiro T, Díaz C, Smani Y, Del Palacio JP, Rodríguez-Baño J, Pascual A, Pachón J, Conejo MC.
Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae.
Front Microbiol.
Palacios-Baena ZR, Delgado-Valverde M, Valiente Méndez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurguí M, de la Calle C, García-Álvarez L, Ramos L, Gozalo M, Morosini MI, Molina J, Causse M, Pascual Á, Rodríguez-Baño J, REIPI/GEIRAS-SEIMC BACTERIEMIA-MIC group.
Impact of de-escalation on prognosis of patients with bacteraemia due to Enterobacteriaceae: a post-hoc analysis from a multicenter prospective cohort.
Clin Infect Dis.
Parra JA, Hernández L, Muñoz P, Blanco G, Rodríguez-Álvarez R, Vilar DR, de Alarcón A, Goenaga MA, Moreno M, Fariñas MC, Spanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES).
Detection of spleen, kidney and liver infarcts by abdominal computed tomography does not affect the outcome in patients with left-side infective endocarditis
Medicine (Baltimore)
Parra-Millán R, Guerrero-Gómez D, Ayerbe-Algaba R, Pachón-Ibáñez ME, Miranda-Vizuete A, Pachón J, Smani Y.
Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB.
mSphere.
Parra-Millán R, Vila-Farrés X, Ayerbe-Algaba R, Varese M, Sánchez-Encinales V, Bayó N, Pachón-Ibáñez ME, Teixidó M, Vila J, Pachón J, Giralt E, Smani Y. J
Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.
Antimicrob Chemother.
Pérez-Arellano JL, Górgolas-Hernández-Mora M, Salvador F, Carranza-Rodríguez C, Ramírez-Olivencia G, Martín-Echeverría E, Rodríguez-Guardado A, Norman F, Velasco-Tirado V, Zubero-Sulibarría Z, Rojo-Marcos G, Muñoz-Gutiérrez J, Ramos-Rincón JM, Sánchez-Seco-Fariñas MP, Velasco-Arribas M, Belhassen-García M, Lago-Nuñez M, Cañas García-Otero E, López-Vélez R.
Executive summary of imported infectious diseases after returning from foreign travel: Consensus document of the Spanish Society for Infectious Diseases and Clinical Microbiology (SEIMC).
Enferm Infecc Microbiol Clin
Pérez-Moreno MA, Peñalva-Moreno G, Praena J, González-González A, Martínez-Cañavate MT, Rodríguez-Baño J, Cisneros JM.
Evaluation of the impact of a nationwide massive online open course on the appropriate use of antimicrobials.
J Antimicrob Chemother.
Pericàs JM, Moreno A, Almela M, García-de-la-Mària C, Marco F, Muñoz P, Peña C, de Alarcón A, Del Río A, Eworo A, Cruceta A, Paré JC, Mestres CA, Miró JM, FOSIMI Investigators.
Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
Clin Microbiol Infect
Pulido MR, Moreno-Martínez P, González-Galán V, Fernández Cuenca F, Pascual Á, Garnacho-Montero J, Antonelli M, Dimopoulos G, Lepe JA, McConnell MJ, Cisneros JM, MagicBullet Working Group
Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia.
Clin Microbiol Infect.
Ramos-Martínez A, Muñoz Serrano A, de Alarcón González A, Muñoz P, Fernández-Cruz A, Valerio M, Fariñas MC, Gutiérrez-Cuadra M, Miró JM, Ruiz-Morales J, Sousa-Regueiro D, Montejo JM, Gálvez-Acebal J, HidalgoTenorio C, Domínguez F, Spanish Collaboration on Endocarditis – Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES).
Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis.
J Infect Chemother
Regueiro A, Falces C, Pericás JM, Muñoz P, Martínez-Sellés M, Valerio M, Sousa Regueiro D, Castelo L, de Alarcón A, Cobo Belaustegui M, Goenaga MA, Hidalgo-Tenorio C, Martínez-Marcos FJ, Gainzarain Arana JC, Miro JM, y los investigadores del Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES).
Risk factors of pericardial effusion in native valve infective endocarditis and its influence on outcome: A multicenter prospective cohort study.
Int J Cardiol.
Russo A, Falcone M, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Cisneros JM, Hernández-Torres A, Farcomeni A, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Rodríguez-Gómez J, Souli M, Bonomo RA, Paterson DL, Carmeli Y, Pascual Á, Rodríguez-Baño J, Venditti M, REIPI/ESGBIS/INCREMENT investigators.
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae
Int J Antimicrob Agents.
Scheuerman O, Schechner V, Carmeli Y, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Molina J, Hernández-Torres A, Venditti M, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Navarro-San Francisco C, Bonomo RA, Paterson DL, Pascual Á, Rodríguez-Baño J, REIPI/ESGBIS/INCREMENT investigators.
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
Infect Control Hosp Epidemiol.
Torres E, López-Cerero L, Morales I, Navarro MD, Rodríguez-Baño J, Pascual A.
Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients.
Clin Microbiol Infect.
Vicent L, Saldívar HG, Bouza E, Muñoz P, Cuerpo G, de Alarcón A, Vidal B, Cobo M, Goenaga MÁ, Carrasco-Chinchilla F, Montejo M, Gálvez-Acebal J, Hidalgo-Tenorio C, Vinuesa-García D, Martínez-Sellés M, GAMES investigators (Appendix 1).
Prognostic implications of a negative echocardiography in patients with infective endocarditis.
Eur J Intern Med.
Zegri-Reiriz I, de Alarcón A, Muñoz P, Martínez Sellés M, González-Ramallo V, Miro JM, Falces C, González Rico C, Kortajarena Urkola X, Lepe JA, Rodríguez Álvarez R, Reguera Iglesias JM, Navas E, Domínguez F, García-Pavía P, Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis infecciosa en España (GAMES).
Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse.
J Am Coll Cardiol.
Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos C, Falantes J, Vázquez-López L, Montero MI, Rosso-Fernández C, de la Luz Martino M, Parody R, González-Campos J, Garzón-López S, Calderón-Cabrera C, Barba P, Rodríguez N, Rovira M, Montero-Mateos E, Carratalá J, Pérez-Simón JA, Cisneros JM.
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Lancet Haematol.
Molina J, Peñalva G, Gil-Navarro MV, Praena J, Lepe JA, Pérez-Moreno MA, Ferrándiz C, Aldabó T, Aguilar M, Olbrich P, Jiménez-Mejías ME, Gascón ML, Amaya-Villar R, Neth O, Rodríguez-Hernández MJ, Gutiérrez-Pizarraya A, Garnacho-Montero J, Montero C, Cano J, Palomino J, Valencia R, Álvarez R, Cordero E, Herrero M, Cisneros JM; PRIOAM team.
Long-Term Impact of an Educational Antimicrobial Stewardship Program on Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections: A Quasi-Experimental Study of Interrupted Time-Series Analysis.
Clin Infect Dis
Nowak J, Zander E, Stefanik D, Higgins PG, Roca I, Vila J, McConnell MJ, Cisneros JM, Seifert H; MagicBullet Working Group WP4.
High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial.
J Antimicrob Chemother
Sánchez-Encinales V, Álvarez-Marín R, Pachón-Ibáñez ME, Fernández-Cuenca F, Pascual A, Garnacho-Montero J, Martínez-Martínez L, Vila J, Tomás MM, Cisneros JM, Bou G, Rodríguez-Baño J, Pachón J, Smani Y.
Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase.
J Infect Dis.
Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos C, Falantes J, Vázquez-López L, Montero MI, Rosso-Fernández C, de la Luz Martino M, Parody R, González-Campos J, Garzón-López S, Calderón-Cabrera C, Barba P, Rodríguez N, Rovira M, Montero-Mateos E, Carratalá J, Pérez-Simón JA, Cisneros JM.
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Lancet Haematol.
Velásquez C, Rivero-Garvía M, Mayorga-Buiza MJ, Cañizares-Méndez ML, Jiménez-Mejías ME, Márquez-Rivas J.
Avoiding pullout complications in external ventricular drains: technical note.
J Neurosurg
Álvarez-Marín R, Aires-de-Sousa M, Nordmann P, Kieffer N, Poirel L.
Antimicrobial activity of octenidine against multidrug-resistant Gram-negative pathogens.
Eur J Clin Microbiol Infect Dis.
Amat T, Gutiérrez-Pizarraya A, Machuca I, Gracia-Ahufinger I, Pérez-Nadales E, Torre-Giménez Á, Garnacho-Montero J, Cisneros JM, Torre-Cisneros J.
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
Clin Microbiol Infect.
Arana-Rueda E, Pedrote A, Frutos-López M, Acosta J, Jauregui B, García-Riesco L, Arce-León Á, Gómez-Pulido F, Sánchez-Brotons JA, Gutiérrez-Carretero E, de Alarcón-González A.
Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.
Clin Cardiol.
Fernández-Cruz A, Muñoz P, Sandoval C, Fariñas C, Gutiérrez-Cuadra M, Pericás Pulido JM, Miró JM, Goenaga-Sánchez MÁ, de Alarcón A, Bonache-Bernal F, Rodríguez M, Noureddine M, Bouza Santiago E, Spanish Collaboration on Endocarditis (GAMES).
Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm?: A prospective, multicenter cohort.
Medicine (Baltimore).
Fernández-Hidalgo N, Ribera A, Larrosa MN, Viedma E, Origüen J, de Alarcón A, Fariñas MC, Sáez C, Peña C, Múñez E, García López MV, Gavaldà J, Pérez-Montarelo D, Chaves F, Almirante B.
Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study.
Clin Microbiol Infect.
Goenaga Sánchez MÁ, Kortajarena Urkola X, Bouza Santiago E, Muñoz García P, Verde Moreno E, Fariñas Álvarez MC, Teira Cobo R, Pericás Pulido JM, de Alarcón González A, Sousa Regueiro D, Ruiz Morales J, Rodríguez-Álvarez RJ, Antorrena Miranda I, Iribarren Loyarte JA, Grupo GAMES.
Aetiology of renal failure in patients with infective endocarditis. The role of antibiotics.
Med Clin (Barc).
Kestler M, Muñoz P, Marín M, Goenaga MA, Idígoras Viedma P, de Alarcón A, Lepe JA, Sousa Regueiro D, Bravo-Ferrer JM, Pajarón M, Costas C, García-López MV, Hidalgo-Tenorio C, Moreno M, Bouza E, Spanish Collaboration on Endocarditis (GAMES).
Endocarditis caused by anaerobic bacteria.
Anaerobe.
Martín-Gutiérrez G, Martín-Pérez C, Gutiérrez-Pizarraya A, Lepe JA, Cisneros JM, Aznar J.
Time to positivity of blood cultures in patients with bloodstream infections: A useful prognostic tool.
Enferm Infecc Microbiol Clin.
Molina J, Peñalva G, Gil-Navarro MV, Praena J, Lepe JA, Pérez-Moreno MA, Ferrándiz C, Aldabó T, Aguilar M, Olbrich P, Jiménez-Mejías ME, Gascón ML, Amaya-Villar R, Neth O, Rodríguez-Hernández MJ, Gutiérrez-Pizarraya A, Garnacho-Montero J, Montero C, Cano J, Palomino J, Valencia R, Álvarez R, Cordero E, Herrero M, Cisneros JM, PRIOAM team.
Long-Term Impact of an Educational Antimicrobial Stewardship Program on Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections: A Quasi-Experimental Study of Interrupted Time-Series Analysis.
Clin Infect Dis.
Nowak J, Zander E, Stefanik D, Higgins PG, Roca I, Vila J, McConnell MJ, Cisneros JM, Seifert H, MagicBullet Working Group WP4.
High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial.
J Antimicrob Chemother.
. Palacios-Baena ZR, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina Gil-Bermejo J, Hernández A, Venditti M, Prim N, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Paño-Pardo JR, Torre-Cisneros J, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual Á, Rodríguez-Baño J, Spanish Network for Research in Infectious Diseases (REIPI)/European Study Group of Bloodstream Infections and Sepsis (ESGBIS)/INCREMENT Group.
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.
Clin Infect Dis.
Ramos-Martínez A, Roque F, Fariñas MC, Muñoz P, Verde E, Cuerpo GP, de Alarcón A, Lepe JA, Miró JM, Plata A, Goenaga MÁ, García-Rosado D, Martínez-Monzonis A, de la Torre J, García-Pavía P, Spanish Collaboration on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES) (see Appendix 1). .
Prognostic factors of infective endocarditis in patients on hemodialysis: A case series from a National Multicenter Registry
Int J Cardiol
Rodríguez-Valero N, Borobia AM, Lago M, Sánchez-Seco MP, de Ory F, Vázquez A, Pérez-Arellano JL, Rodríguez CC, Martínez MJ, Capón A, Cañas E, Salas-Coronas J, Galparsoro AA, Muñoz J.
Zika Virus Screening among Spanish Team Members After 2016 Rio de Janeiro, Brazil, Olympic Games.
Emerg Infect Dis.
Torres E, López-Cerero L, Morales I, Navarro MD, Rodríguez-Baño J, Pascual A.
Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients.
Clin Microbiol Infect.
Vila-Farrés X, Parra-Millán R, Sánchez-Encinales V, Varese M, Ayerbe-Algaba R, Bayó N, Guardiola S, Pachón-Ibáñez ME, Kotev M, García J, Teixidó M, Vila J, Pachón J, Giralt E, Smani Y.
Combating virulence of Gram-negative bacilli by OmpA inhibition.
Sci Rep.
Otero F, Santiso R, Tamayo M, Fernández JL, Bou G, Lepe JA, McConnell MJ, Gosálvez J, Cisneros JM.
Rapid Detection of Antibiotic Resistance in Gram-Negative Bacteria Through Assessment of Changes in Cellular Morphology
Microb Drug Resist
Morales-Barroso I, López-Cerero L, Molina J, Bellido M, Navarro MD, Serrano L, González-Galán V, Praena J, Pascual A, Rodríguez-Baño J.
Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes
Int J Antimicrob Agents.
Hernández Quiles C, Bernabeu Wittel M, Praena Segovia J, Ternero Vega J, Díez Manglano J, Jarava Rol G, Ollero Baturone M.
Comparison surprise question against a target index (PALIAR Index) for identifying terminal status in patients with advanced chronic disease.
Rev Clin Esp.
Gudiol C, Royo-Cebrecos C, Tebe C, Abdala E, Akova M, Álvarez R, Maestro-de la Calle G, Cano A, Cervera C, Clemente WT, Martín-Dávila P, Freifeld A, Gómez L, Gottlieb T, Gurguí M, Herrera F, Manzur A, Maschmeyer G, Meije Y, Montejo M, Peghin M, Rodríguez-Baño J, Ruiz-Camps I, Sukiennik TC, Carratalà J, BICAR study group.
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR).
BMJ Open.
Gutiérrez Carretero E, Arana Rueda E, Lomas Cabezas JM, Laviana Martínez F, Villa Gil-Ortega M, Acosta Martínez J, Pedrote Martínez A, de Alarcón González A.
Infections in Cardiac Implantable Electronic Devices: Diagnosis and Management in a Referral Center.
Rev Esp Cardiol (Engl Ed).
. Fernández-López R, de-Bonilla-Damiá A, Acevedo-Báñez I, Luque-Márquez R, Borrego-Dorado I.
F-FDG PET/CT in a case of suspected vascular graft infection.
Rev Esp Med Nucl Imagen Mol.
Álvarez-Marín R, López-Rojas R, Márquez JA, Gómez MJ, Molina J, Cisneros JM, Ortiz-Leyba C, Aznar J, Garnacho-Montero J, Pachón J.
Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.
PLoS One.
Martín-Gutiérrez G, Martín-Pérez C, Gutiérrez-Pizarraya A, Lepe JA, Cisneros JM, Aznar J.
Time to positivity of blood cultures in patients with bloodstream infections: A useful prognostic tool.
Enferm Infecc Microbiol Clin.
Cisneros JM, Rodríguez-Baño J.
Why is it so difficult in Spain to get funding to combat antimicrobial resistance?.
Enferm Infecc Microbiol Clin.
López M, Rueda A, Florido JP, Blasco L, Gato E, Fernández-García L, Martínez-Martínez L, Fernández-Cuenca F, Pachón J, Cisneros JM, Garnacho-Montero J, Vila J, Rodríguez-Baño J, Pascual A, Bou G, Tomás M.
Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010).
Genome Announc.
Otero F, Santiso R, Tamayo M, Fernández JL, Bou G, Lepe JA, McConnell MJ, Gosálvez J, Cisneros JM.
Rapid Detection of Antibiotic Resistance in Gram-Negative Bacteria Through Assessment of Changes in Cellular Morphology.
Microb Drug Resist.
Otero F, Santiso R, Tamayo M, Fernández JL, Bou G, Lepe JA, McConnell MJ, Gosálvez J, Cisneros JM.
Rapid Detection of Antibiotic Resistance in Gram-Negative Bacteria Through Assessment of Changes in Cellular Morphology.
Microb Drug Resist.
Blanco-Lobo P, González-Galán V, García-Quintanilla M, Valencia R, Cazalla A, Martín C, Alonso I, Pérez-Romero P, Cisneros JM, Aznar J, McConnell MJ.
Clinical validation of a real-time polymerase chain reaction assay for rapid detection of Acinetobacter baumannii colonization.
J Hosp Infect.
Álvarez R, López Cortés LE, Molina J, Cisneros JM, Pachón J.
Optimizing the Clinical Use of Vancomycin.
Antimicrob Agents Chemother.